Introduction
The placenta of the goat produces insufficient progesterone to maintain pregnancy at any stage of gestation; ovariectomy during pregnancy invariably causes abortion (Drummond-Robinson & Asdell, 1926; Meites, Webster, Young, Thorp & Hatch, 1951; Cowie, Daniel, Prichard & Tindal, 1963) . However, the uptake of progesterone by the gravid uterus decreases after approximately 110 days gestation (Thorburn & Schneider, 1972) , and the placenta contains 3 ß-hydroxysteroid dehydrogenase after Day 116 (Wiener, 1976; Flint, Kingston, Robinson & Thorburn, 1978) . Therefore it seems possible that the placenta may produce small amounts of progesterone during late pregnancy.
To determine the placental contribution to circulating progesterone concentrations in late pregnancy we have measured plasma progesterone levels in ovariectomized goats in which pregnancy was maintained with a synthetic progestagen, medroxyprogesterone acetate (MPA). Data are also presented on the effects of MPA on plasma oestrogen levels and milk yields. Materials and Methods Animals. Sixteen Saanen goats of the Institute's herd were used; with 2 exceptions they were studied in their first pregnancies. For measurement of peripheral progesterone concentrations the ovaries (1 animal) or corpora lutea (3 animals) were removed after mid-line ventral laparotomy, using aseptic surgical techniques, between 71 and 96 days gestation. Anaesthesia was induced with intravenous pentobarbitone sodium and maintained after endotracheal intubation with halothane in oxygen in a closed-circuit system. When necessary ovarian vessels exposed after excision of corpora lutea (lutectomy) were Measurement of progesterone and oestrogens. Concentrations of progesterone and total unconjugated oestrogens (oestradiol-17ß plus oestradiol-17a plus oestrone) were measured in plasma by radioimmunoassay s described elsewhere (Flint, Anderson, Patten & Turnbull, 1974; Sheldrick, Mitchell & Flint, 1980) . These assays have previously been validated for plasma from goats (Flint et al., 1978) ; for the progesterone and oestrogen assays the respective values were 84 and 91% for mean extraction recovery, 8-5 and 8-6% for intra-assay coefficient of variation, and 5-4 and 4-0% for the inter-assay coefficient of variation. The sensitivities were 0-016 ng progesterone/ml and 5-6 pg total oestrogens/ml.
For measurement of progesterone in plasma from ovariectomized or lutectomized goats it was necessary to purify the extracts before assay, and this was achieved by reverse-phase chromatography on columns of celite (Abraham, Hopper, Tulchinsky, Swerdloff & Odell, 1971) . The need for a purification step was demonstrated by assaying these samples with and without purification. For intact animals, samples after chromatography gave 91 ± 6-7% (mean + s.e.m., = 10) of the concentration before chromatography; for ovariectomized/lutectomized animals the corresponding value was 57 ± 13-4% (n = 5). The blank value in the progesterone assay, determined in an ovariectomized animal post partum, was 34 pg/ml.
Radioimmunoassay cannot be regarded as providing unequivocal identification of a compound because of the limited specificity of antisera, and therefore possible cross-reactants in the progesterone assay were considered. The major known cross-reactants with the antibody used are 11-deoxycorticosterone, 5a-pregnanedione and pregnenolone, which interact at 4-0%, 2-0%, and 1-5% respectively. To assess the possible contribution of these compounds, an extract of plasma from an ovariectomized, MPA-treated goat on Day 135 was chromatographed on celite before being subjected to thin layer chromatography. Assay of consecutive bands from the thin-layer plate showed no cross-reacting material co-chromatographing with 11-deoxycorticosterone, pregnenolone or 5a-pregnanedione (Text- fig. 1 ). An important metabolite of progesterone in vitro, which is known to circulate at high concentrations in late gestation, is 5ß-pregnane-3a,20a-diol (Flint et al, 1978 overnight at 4°C. To separate free and bound steroid, 0-5 ml of a solution of polyethylene glycol-6000 (30% w/v in water) was added, and after vortex mixing for 1 min, -globulins were sedimented by centrifugation (1000 g for 30 min). Supernatants were removed and discarded, and pellets resuspended in 1 ml water before adding to 5 ml toluene-based scintillation fluid. Samples were counted after shaking and standing for 8 h. Extraction recovery was 78-6 ± 2-6% (mean ± s.e.m., = 5) and values were corrected for losses at this stage. The sensitivity of the assay (determined from 2 s.d. about the zero point) was 0-18 ng, and the blank value (plasma from untreated pregnant goats) was 0-12 ng/ml (n = 9). Intra-and inter-assay coefficients of variation were 11-4% (n = 12) and 9-0% (n = 5) respectively. The antibody showed negligible cross-reaction with all the naturally occurring steroids tested: cross-reactions with deoxycorticosterone, corticosterone, progesterone, 17a-hydroxyprogesterone, 5ß-pregnane-3a,20a-diol, oestradiol-17a, oestradiol-17ß and oestrone were below 0-01% (confirming the data of Cornette et ai, 1971).
For the assay of MPA in milk, samples of colostrum or whole milk (0-1 ml) were diluted with 0-4 ml water and extracted with 5 ml diethyl ether. (Peaker, 1978 Text- fig. 3 ). The oestrogen level increased during the last week of pregnancy in all treatment groups; the mean concentrations (± s.e.m.) at 136-147 and 148-153 days were 1-56 ± 0-16 (n = 35 samples) and 2-09 ± 0-22 ng/ml (n = 16; < 0-02) respectively. ranged from 2-1 to 9-4 ng/ml (mean ± s.e.m. 4-61 + 1-63 ng/ml for 4 animals). However, MPA disappeared at least as rapidly from milk as from plasma after delivery and the end of treatment; in 2 animals in which plasma and milk levels were measured simultaneously it had dropped by 87% within 20-27 days of the start of lactation compared with a decline of 75% in plasma.
Discussion
Measurement of circulating progesterone concentrations in ovariectomized or lutectomized goats showed that the level increased between 130 and 142 days and subsequently dropped before term. Veno-arterial differences across the uterus suggested that the placenta was secreting progesterone between Days 128 and 141. This confirms circumstantial evidence described in the 'Introduction'. The mechanism underlying increased placental progesterone production in late pregnancy is not known; it may be related to the mechanism controlling the increase in progesterone secretion by the placenta in the sheep at about 50-70 days gestation, which is itself poorly understood (Thorburn, Challis & Robinson, 1977; Ricketts & Flint, 1980) . The fact that ovariectomy or lutectomy has no effect on circulating oestrogen levels, which are influenced primarily by fetal weight, is consistent with the proposal that the ovary is not a major source of oestrogens during pregnancy in the goat (see Currie & Thorburn, 1977 ). An alternative source of oestrogens, and one which would not be expected to be affected by ovariectomy or lutectomy, is the mammary gland, and this has been shown to produce a large proportion of the oestrogen circulating near term (Maule Walker & Peaker, 1978) .
The fall in the circulating concentration of progesterone during the last week of pregnancy in intact goats reflects luteal regression (Currie & Thorburn, 1977) . The cause of the decrease in progesterone before term in ovariectomized or lutectomized animals treated with MPA (Text- fig.  2 ) is less certain. One possibility is that it results from the activation or induction of placental enzymes which metabolize C21 steroids to oestrogens; an increase in placental 17a-hydroxylase activity in response to raised fetal glucocorticoid concentrations has been implicated in the mechanisms leading to the onset of labour in goats (Flint et al., 1978) , and a similar series of events is thought to occur, and to cause a decrease in placental progesterone secretion, in sheep before parturition (see Flint & Ricketts, 1979) .
Progesterone levels in intact goats receiving MPA were consistently reduced relative to those in untreated animals. This effect, which was not accounted for by any differences in the incidence of multiple pregnancies in this group, suggests that MPA reduces luteal progesterone secretion. This may be brought about through inhibition of LH release; the corpus luteum is LH-dependent in late pregnancy in the goat (Buttle, 1978) , and LH levels are reduced in sheep by chronic progestagen treatment (see Karsch, Legan, Ryan & Foster, 1978) . Some inhibition of LH release might be expected if the progestational effect of circulating MPA was greater than that normally exerted in pregnancy by progesterone. The potency of MPA has been quoted as 30-40 times greater than that of progesterone in the rat and guinea-pig (Miyake & Pincus, 1958; Illingworth & Deanesly, 1972) ; if this is also true for the goat, then the circulating MPA concentration (which reached 0-6-0-8 ng/ml; Text- fig. 4 ) is equivalent to a concentration of progesterone of 18-36 ng/ml, which is above the normal range (Table 1) .
MPA has been shown to inhibit 3 ß-hydroxysteroid dehydrogenase in human corpus luteum and rat testis (Johansson, 1971; Satyaswaroop & Gurpide, 1978; Shinada, Yokota & Igarashi, 1978) and it may therefore have a direct effect in reducing progesterone secretion by the placenta. If this, did occur it might lead to underestimation of the placental contribution to circulating progesterone levels. However, MPA treatment had no effect on oestrogen concentrations, and any inhibitory effect on steroid synthesis in the placenta is likely, therefore, to be small; this may reflect the low peripheral concentrations of MPA in vivo, compared to those shown to be inhibitory in vitro.
Treatment with MPA during pregnancy reduced milk yield during the subsequent lactation. Although this effect was observed in animals which-underwent Caesarean section, it did not appear to be caused by surgical delivery of the kids; lactational yields were also low in the one intact MPA-treated animal which delivered spontaneously. This effect was not unexpected; MPA used as a long-term contraceptive interferes with lactation in some women (Parveen, Chowdhury & Chowdhury, 1977) , and a reduction in circulating progesterone concentration is an important factor controlling lactogenesis in goats (Davis et al., 1979) and sheep (Hartmann, Trevethan & Shelton, 1973) . The MPA preparations used in the present study (Depo-Provera & Promone-E) are long-acting, microcrystalline formulations released over a long period in primates (Cornette et al., 1971; Kirton & Cornette, 1974; Shrimanker, Saxena & Fotherby, 1978) , and MPA was found in the circulation of the goats 1-2 months after the end of treatment. Nonetheless, the level did drop dramatically during early lactation, and it is possible that the decreasing levels of MPA and the rising milk yield in treated animals are causally related. The mechanism whereby MPA reduces milk yield is uncertain. Since progesterone reduces oxytocin release in response to vaginal distension in goats (Roberts, 1975) MPA may reduce oxytocin secretion in response to milking, thereby preventing normal let down of milk; however, administration of oxytocin during milking did not increase milk yield in MPA-treated animals (E. L. Sheldrick, unpublished observations). An alternative mechanism is that MPA treatment reduces the mammary prolactin receptor concentration, as does progesterone in the rat (Djiane 
